Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Small extracellular vesicles can help diagnose and manage sepsis.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

CBD can either promote or inhibit hair growth depending on the concentration used.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

JAK inhibitors show promise for treating skin diseases effectively and safely.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Notch1 helps skin heal by attracting specific immune cells.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

More research is needed on alopecia areata treatments and its psychological effects.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.